<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lachance DH</submitter><funding>NCI NIH HHS</funding><pagination>574-81</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3202152</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>174(5)</volume><pubmed_abstract>Glioma risk has consistently been inversely associated with allergy history but not with smoking history despite putative biologic plausibility. Data from 855 high-grade glioma cases and 1,160 controls from 4 geographic regions of the United States during 1997-2008 were analyzed for interactions between allergy and smoking histories and inherited variants in 5 established glioma risk regions: 5p15.3 (TERT), 8q24.21 (CCDC26/MLZE), 9p21.3 (CDKN2B), 11q23.3 (PHLDB1/DDX6), and 20q13.3 (RTEL1). The inverse relation between allergy and glioma was stronger among those who did not (odds ratio(allergy-glioma) = 0.40, 95% confidence interval: 0.28, 0.58) versus those who did (odds ratio(allergy-glioma) = 0.76, 95% confidence interval: 0.59, 0.97; P(interaction) = 0.02) carry the 9p21.3 risk allele. However, the inverse association with allergy was stronger among those who carried (odds ratio(allergy-glioma) = 0.44, 95% confidence interval: 0.29, 0.68) versus those who did not carry (odds ratio(allergy-glioma) = 0.68, 95% confidence interval: 0.54, 0.86) the 20q13.3 glioma risk allele, but this interaction was not statistically significant (P = 0.14). No relation was observed between glioma risk and smoking (odds ratio = 0.92, 95% confidence interval: 0.77, 1.10; P = 0.37), and there were no interactions for glioma risk of smoking history with any of the risk alleles. The authors' observations are consistent with a recent report that the inherited glioma risk variants in chromosome regions 9p21.3 and 20q13.3 may modify the inverse association of allergy and glioma.</pubmed_abstract><journal>American journal of epidemiology</journal><pubmed_title>Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking.</pubmed_title><pmcid>PMC3202152</pmcid><funding_grant_id>P50 CA097257</funding_grant_id><funding_grant_id>P50 CA108786</funding_grant_id><funding_grant_id>P50 CA108961</funding_grant_id><funding_grant_id>5P50CA108786-4</funding_grant_id><funding_grant_id>P50CA097257</funding_grant_id><funding_grant_id>R01 CA052689</funding_grant_id><funding_grant_id>R01CA52689</funding_grant_id><pubmed_authors>Wrensch MR</pubmed_authors><pubmed_authors>Buckner JC</pubmed_authors><pubmed_authors>Lachance DH</pubmed_authors><pubmed_authors>Patoka JS</pubmed_authors><pubmed_authors>Ali-Osman F</pubmed_authors><pubmed_authors>Wang F</pubmed_authors><pubmed_authors>Kollmeyer TM</pubmed_authors><pubmed_authors>Rice T</pubmed_authors><pubmed_authors>Wiencke JK</pubmed_authors><pubmed_authors>Davis F</pubmed_authors><pubmed_authors>Worra JB</pubmed_authors><pubmed_authors>Jenkins RB</pubmed_authors><pubmed_authors>Johnson DR</pubmed_authors><pubmed_authors>Kosel ML</pubmed_authors><pubmed_authors>Xiao Y</pubmed_authors><pubmed_authors>O'Neill BP</pubmed_authors><pubmed_authors>Stoddard SM</pubmed_authors><pubmed_authors>Sprau DJ</pubmed_authors><pubmed_authors>Il'yasova D</pubmed_authors><pubmed_authors>Wiemels JL</pubmed_authors><pubmed_authors>Yang P</pubmed_authors><pubmed_authors>Rynearson AL</pubmed_authors><pubmed_authors>Fridley BL</pubmed_authors><pubmed_authors>McCoy LS</pubmed_authors><pubmed_authors>Decker PA</pubmed_authors><pubmed_authors>McCarthy B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking.</name><description>Glioma risk has consistently been inversely associated with allergy history but not with smoking history despite putative biologic plausibility. Data from 855 high-grade glioma cases and 1,160 controls from 4 geographic regions of the United States during 1997-2008 were analyzed for interactions between allergy and smoking histories and inherited variants in 5 established glioma risk regions: 5p15.3 (TERT), 8q24.21 (CCDC26/MLZE), 9p21.3 (CDKN2B), 11q23.3 (PHLDB1/DDX6), and 20q13.3 (RTEL1). The inverse relation between allergy and glioma was stronger among those who did not (odds ratio(allergy-glioma) = 0.40, 95% confidence interval: 0.28, 0.58) versus those who did (odds ratio(allergy-glioma) = 0.76, 95% confidence interval: 0.59, 0.97; P(interaction) = 0.02) carry the 9p21.3 risk allele. However, the inverse association with allergy was stronger among those who carried (odds ratio(allergy-glioma) = 0.44, 95% confidence interval: 0.29, 0.68) versus those who did not carry (odds ratio(allergy-glioma) = 0.68, 95% confidence interval: 0.54, 0.86) the 20q13.3 glioma risk allele, but this interaction was not statistically significant (P = 0.14). No relation was observed between glioma risk and smoking (odds ratio = 0.92, 95% confidence interval: 0.77, 1.10; P = 0.37), and there were no interactions for glioma risk of smoking history with any of the risk alleles. The authors' observations are consistent with a recent report that the inherited glioma risk variants in chromosome regions 9p21.3 and 20q13.3 may modify the inverse association of allergy and glioma.</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011 Sep</publication><modification>2024-11-06T16:21:24.461Z</modification><creation>2019-03-27T00:45:24Z</creation></dates><accession>S-EPMC3202152</accession><cross_references><pubmed>21742680</pubmed><doi>10.1093/aje/kwr124</doi></cross_references></HashMap>